Matt Hawkins

Matt Hawkins

Contributing Writer, Kiplinger.com

Matt Hawkins is the Founder and Managing Partner of Entourage Effect Capital. He has 20-plus years of private equity experience and has founded multiple $500 million-plus alternative firms. Matt also serves on the boards of numerous cannabis companies.

Matt brings an extensive background in building large alternative investment firms and scaling the companies he invests in. In 2014, Matt had a vision to create the leading private equity firm focused specifically on investing in the legalized cannabis industry. Prior work highlights:

  • Partner and President, Tucson Capital Partners: Private equity firm focused on multifamily residential and self-storage assets. Between 2008 and 2013, the company completed more than 55 bank-direct acquisitions, deploying more than $500 million of capital. He successfully exited in 2013.
  • Principal & Co-founder of Adjacent Capital: Private equity/specialty lending fund where he oversaw the sourcing, origination, structuring and closing of over 60 transactions in a three-year period.
  • He also became a turnaround specialist through his time at Treadstone Partners and San Jacinto Partners. He is known and respected in the cannabis industry as one of the successful early investors.

Matt can be reached at MHawkins@eecpartners.com.

The Pros and Cons of Marijuana MSOs
A jar of commercial marijuana
marijuana stocks

The Pros and Cons of Marijuana MSOs

Multi-state operators are an important category within cannabis investing. But what sets MSOs apart, and how do you invest in them?
September 22, 2021
How to Invest in Cannabis (Without Buying Cannabis Stocks)
Cannabis leaves
marijuana stocks

How to Invest in Cannabis (Without Buying Cannabis Stocks)

Ancillary companies provide cannabis businesses with materials, technology and services without ever "touching" the plant.
July 2, 2021
Investing in Cannabis? Beware These Red Flags
Marijuana leaf
marijuana stocks

Investing in Cannabis? Beware These Red Flags

Due diligence is particularly critical when investing in cannabis firms given the numerous regulations the industry faces, as well as a rapidly shifti…
April 19, 2021